- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 96.52M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 72.42M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 70.95M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $8.53M |
| Capex | Q1 2026 · Mar 31, 2026 | $2.16M |
| Capex | Q1 2026 · Mar 31, 2025 | $94K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$23.64M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$13.08M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $325K |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $330K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$139.11M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$73.6M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | −$13.12M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | −$906K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $14.91M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $64.3M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $104.16M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $154.18M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $130.01M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $70.93M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $145.38M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $80.58M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.27 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.18 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.27 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.18 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $14.09M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $4.52M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $14.09M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $6.68M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$90.42M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$12.73M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$27.01M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$11.4M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $1.81M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $154K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.64M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $714K |
| Revenue | Q1 2026 · Mar 31, 2026 | $1M |
| Revenue | Q1 2026 · Mar 31, 2025 | $868K |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $12.78M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $19.27M |